Naomi Berrie Diabetes Center

What Naomi Berrie Diabetes Center does

Naomi Berrie Diabetes Center is a specialized diabetes care and research center operating as a non-profit unit within Columbia University Irving Medical Center, located at 630 West 168th Street in New York City. The center delivers comprehensive diabetes care across three program lines: a Pediatric Diabetes Program for children and adolescents, an Adult Diabetes Program for ongoing adult disease management, and a Diabetes Transition Program that supports continuity of care as patients move from pediatric to adult services. It serves thousands of patients, including an international patient base that travels to the center for specialized treatment. The center co-locates clinical operations with on-site research laboratories, enabling direct translation of scientific advances into patient treatments, and operates what it describes as one of the country's largest clinical trials programs for type 1 diabetes.

The center's distribution is primarily regional, centered on its single New York facility, supplemented by telehealth/virtual visit services delivered through the Columbia Connect patient portal. Patient access occurs via scheduled appointments, physician referrals through the ColumbiaDoctors network, insurance billing, and self-referrals, with clinical trials serving as an additional acquisition channel for research-eligible patients. Marketing and patient engagement are conducted through ColumbiaDoctors' institutional website, the patient portal, a clinical trials directory, and a Find a Doctor tool that spans more than 30 specialties within the broader Columbia ecosystem.

The center is not independently financed; it operates as an integral part of Columbia University Irving Medical Center, and its revenue (not publicly disclosed) is generated through billed patient care services and clinical trial activity. It holds no patents, trademarks, or independent funding rounds in the source data, and reports 11-50 employees. Competitive advantage is anchored in the Columbia University brand, access to academic research infrastructure, longitudinal patient data, and embedded position within the ColumbiaDoctors specialty care network rather than in proprietary technology.

Name

Naomi Berrie Diabetes Center

Legal name

Naomi Berrie Diabetes Center

Website

https://nbdiabetes.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Naomi Berrie Diabetes Center is a non-profit diabetes care and research center within Columbia University Irving Medical Center in New York City, serving thousands of pediatric and adult patients through on-site clinical programs, on-site research laboratories, and one of the country's largest type 1 diabetes clinical trials programs.

Ownership category

akta.pro rank

Product category

Diabetes Care and Endocrinology Services

NAICS

Offices of Physicians (6211), All Other Outpatient Care Centers (621498)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Diabetes (General) (HLAKADAA)

akta.pro secondary industries

Type 1 Diabetes Care (HLAKADAB), Type 2 Diabetes Care (HLAKADAC), Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD)

Keywords

• Diabetes care services
• Pediatric endocrinology
• Diabetes clinical trials
• Diabetes research programs
• Telehealth endocrinology

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Revenue generated through patient care services billed to insurance providers and patients directly. Services include adult diabetes program, pediatric diabetes program, diabetes transition program, and telehealth services.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Naomi Berrie Diabetes Center provides comprehensive diabetes care for patients across the lifespan, offering specialized Pediatric Diabetes, Adult Diabetes, and Diabetes Transition Programs, along with telehealth services and one of the country's largest type 1 diabetes clinical trials programs. The center operates on-site research laboratories that translate scientific advances into clinical treatments, all within the Columbia University Irving Medical Center campus.

Product overview

Naomi Berrie Diabetes Center operates as a single unified healthcare center rather than a platform-plus-modules architecture. The center provides comprehensive diabetes care through integrated programs: Pediatric Diabetes Program (for children/adolescents), Adult Diabetes Program (for adult patients), and Diabetes Transition Program (helping young patients move from pediatric to adult care). The center's research laboratories are co-located with clinical care, enabling direct translation of scientific advances into treatments. Patient services are supported by Columbia Connect, a patient portal for appointment management, test results access, and telehealth/virtual visits.

Differentiator

Problem solved

Functional benefit

Products and services

• Pediatric Diabetes Program Specialized diabetes care program designed for children and adolescents, offering age-appropriate treatment and family-centered support for pediatric diabetes management.
• Adult Diabetes Program Comprehensive diabetes management program for adult patients, providing individualized treatment plans and ongoing care for diabetes management.
• Diabetes Transition Program Program designed to help young patients transition from pediatric to adult diabetes care, ensuring continuity of treatment during life transitions.
• Diabetes Clinical Trials Program Clinical trials program for diabetes (particularly type 1 diabetes), offering patients access to research-backed studies and emerging treatments through one of the country's largest type 1 diabetes clinical trials programs.
• Telehealth and Virtual Visit Services Virtual visits and telehealth appointments enabling remote patient consultations, accessible via the Columbia Connect patient portal.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Columbia University Irving Medical CentercoreStrategic or Co-development PartnerThe Naomi Berrie Diabetes Center is an integral part of Columbia University Irving Medical Center, operating under the ColumbiaDoctors network. Research laboratories are located on the same campus, enabling direct translation of scientific advances into clinical treatments.

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• International Diabetes Center (HealthPartners): Park Nicollet/HealthPartners-affiliated diabetes center offering clinical care, education, and research with a national reputation in diabetes management protocols — a comparable specialty-focused delivery model.
• Barbara Davis Center for Diabetes: University of Colorado-affiliated center focused on type 1 diabetes care and research with large pediatric and adult patient populations — closely mirrors NBDC's research-clinical integration model.
• Joslin Diabetes Center: Harvard-affiliated diabetes research and clinical care center offering adult and pediatric programs with deep clinical-trial capacity — the most directly comparable specialty diabetes center in the U.S.

Others

• Beyond Type 1: T1D-focused advocacy and digital health nonprofit with disease-education and community platforms — adjacent ecosystem player that channels patient awareness and trial recruitment for centers like NBDC.
• JDRF (formerly Juvenile Diabetes Research Foundation): Leading T1D research funder and advocacy organization; not a clinical operator but a key counterpart that funds trial infrastructure and shapes T1D research priorities that drive NBDC's clinical trial pipeline.

Broad incumbents

• Cleveland Clinic Endocrinology & Metabolism Institute: Major multi-specialty academic system with a dedicated endocrinology institute offering diabetes care, technology integration, and research — competes for complex cases and biopharma-sponsored trials.
• Stanford Medicine Endocrinology: West-coast academic endocrinology program with research strengths in diabetes technology and T1D — competes for clinical trial enrollment and high-acuity referrals nationally.
• Mayo Clinic Division of Endocrinology: Large multi-specialty academic medical center with an endocrinology division providing diabetes care and clinical research at greater scale and geographic reach — a broad incumbent competing for complex diabetes referrals.

Regional players

• NYU Langone Endocrinology: New York-based academic endocrinology and diabetes program offering overlapping adult/pediatric diabetes care and clinical research in the same metropolitan market — a local competitive counterpart.

Emerging players

• Stanford Diabetes Research Center: Stanford-affiliated diabetes research consortium focused on T1D cure-oriented research; an emerging research counterpart whose trial activity can overlap with or compete against NBDC's pipeline.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/nbdiabetes
• Facebookfacebook.com/nbdiabetes
• LinkedInlinkedin.com/company/naomi-berrie-diabetes-ctr

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Naomi Berrie Diabetes Center